Search research articles
Contact Us
Filters
Showing results (371-380 of 525) with videos related to
Page
of 53
Sort By:
Journal of Labelled Compounds & Radiopharmaceuticals
|
February 12, 2021
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [<sup>111</sup> In]In-XYIMSR-01 for phase I regulatory approval
Ravindra A De Silva, Michael A Gorin, Ronnie C Mease, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Liang Dong, Yun Su, Yinjie Zhu, et al.
Cancers
|
January 21, 2022
Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT
Patrick W Mihatsch, Matthias Beissert, Martin G Pomper, et al.
Science Advances
|
July 9, 2019
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
Il Minn, David J Huss, Hye-Hyun Ahn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 5, 2023
SUV
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 28, 2015
Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates
Sangeeta Ray Banerjee, Catherine A Foss, Mrudula Pullambhatla, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 28, 2021
<sup>68</sup>Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent
Xiaojiang Duan, Zhen Cao, Hua Zhu, et al.
Journal of Parkinson'S Disease
|
February 20, 2025
Cortical α4β2-nicotinic acetylcholine receptors and cognitive decline in Parkinson's disease
Kelly A Mills, Hiroto Kuwabara, Yong Du, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
Rudolf A Werner, Thorsten Derlin, Steven P Rowe, et al.
Scientific Reports
|
May 7, 2021
Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers
Hye-Hyun Ahn, Christine Carrington, Yizong Hu, et al.
Page
of 53
Search research articles
Search
Showing results (371-380 of 525) with videos related to
Sort By:
Page
of 53
Journal of Labelled Compounds & Radiopharmaceuticals
|
February 12, 2021
Process validation, current good manufacturing practice production, dosimetry, and toxicity studies of the carbonic anhydrase IX imaging agent [<sup>111</sup> In]In-XYIMSR-01 for phase I regulatory approval
Ravindra A De Silva, Michael A Gorin, Ronnie C Mease, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
July 30, 2021
The European Association of Urology Biochemical Recurrence Risk Groups Predict Findings on PSMA PET in Patients with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
Liang Dong, Yun Su, Yinjie Zhu, et al.
Cancers
|
January 21, 2022
Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT
Patrick W Mihatsch, Matthias Beissert, Martin G Pomper, et al.
Science Advances
|
July 9, 2019
Imaging CAR T cell therapy with PSMA-targeted positron emission tomography
Il Minn, David J Huss, Hye-Hyun Ahn, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 5, 2023
SUV
Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 28, 2015
Preclinical evaluation of 86Y-labeled inhibitors of prostate-specific membrane antigen for dosimetry estimates
Sangeeta Ray Banerjee, Catherine A Foss, Mrudula Pullambhatla, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 28, 2021
<sup>68</sup>Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent
Xiaojiang Duan, Zhen Cao, Hua Zhu, et al.
Journal of Parkinson'S Disease
|
February 20, 2025
Cortical α4β2-nicotinic acetylcholine receptors and cognitive decline in Parkinson's disease
Kelly A Mills, Hiroto Kuwabara, Yong Du, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
High Interobserver Agreement for the Standardized Reporting System SSTR-RADS 1.0 on Somatostatin Receptor PET/CT
Rudolf A Werner, Thorsten Derlin, Steven P Rowe, et al.
Scientific Reports
|
May 7, 2021
Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers
Hye-Hyun Ahn, Christine Carrington, Yizong Hu, et al.
Page
of 53